EUVIMEDEUVIMED entdecken
Crossref

Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations

Fumihiro Terasaki iD, Teiichi Sugiura iD, Yukiyasu Okamura iD, Ryo Ashida iD, Katsuhisa Ohgi, Mihoko Yamada iD, Shimpei Ohtsuka iD, Katsuhiko Uesaka iD

Journal of Hepato-Biliary-Pancreatic Sciences · 2024

DOI: 10.1002/jhbp.1387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2024. Verfasst von Fumihiro Terasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Lymph Node Excision, Cholangiocarcinoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The benefits of lymph node (LN) dissection at each station have not previously been fully investigated in perihilar cholangiocarcinoma (PHCC) and distal cholangiocarcinoma (DCC).

Methods

The efficacy index (EI) was calculated in patients who underwent surgery for PHCC ( n = 134) and DCC ( n = 135) by multiplying the frequency of metastasis to the LN station and the 5‐year overall survival (OS) rate of patients with metastasis to that station.

Results

In PHCC, the frequency of metastasis, 5‐year OS rates, and the EI in para‐aortic LNs (4.7%, 0%, and 0, respectively) and posterior pancreaticoduodenal LNs (8.1%, 0%, and 0, respectively) were lower than those in hepatoduodenal ligament LNs (30.1%, 24.1%, and 7.25, respectively) and LNs along the common hepatic artery (CHA) (16.2%, 15.0%, and 2.43, respectively). In DCC, these values were lower in LNs along the CHA (6.4%, 0%, and 0, respectively) than in the posterior pancreaticoduodenal LNs (31.2%, 34.5%, and 10.8, respectively), the hepatoduodenal ligament LNs (14.8%, 15.2%, and 2.25, respectively), and para‐aortic (4.0%, 25.0%, and 0.99, respectively) LNs.

Conclusions

According to the EI, this study raises concerns about the effectiveness of dissection in the posterior pancreaticoduodenal LNs in PHCC and LNs along the CHA in DCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsLymph Node ExcisionCholangiocarcinomaHumansMaleFemaleAgedMiddle AgedRetrospective StudiesLymphatic MetastasisKlatskin TumorSurvival RateNeoplasm StagingLymph NodesAged, 80 and overAdult

Stichwörter der Autor:innen

distal cholangiocarcinomalymph node dissectionlymph node stationperihilar cholangiocarcinomaregional lymph nodes

Autor:innen und Institutionen

  • Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.

ORCID-Profile: Fumihiro Terasaki, Teiichi Sugiura, Yukiyasu Okamura, Ryo Ashida, Mihoko Yamada, Shimpei Ohtsuka, Katsuhiko Uesaka

Zitieren

APA

Terasaki, F., Sugiura, T., Okamura, Y., Ashida, R., Ohgi, K., Yamada, M., Ohtsuka, S., & Uesaka, K. (2024). Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.1387

Vancouver

Terasaki F, Sugiura T, Okamura Y, Ashida R, Ohgi K, Yamada M, et al. Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations. Journal of Hepato-Biliary-Pancreatic Sciences. 2024. doi:10.1002/jhbp.1387

BibTeX
@article{Terasaki2024,
  author = {Terasaki, Fumihiro and Sugiura, Teiichi and Okamura, Yukiyasu and Ashida, Ryo and Ohgi, Katsuhisa and Yamada, Mihoko and Ohtsuka, Shimpei and Uesaka, Katsuhiko},
  title = {Benefit of lymph node dissection for perihilar and distal cholangiocarcinoma according to lymph node stations},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2024},
  doi = {10.1002/jhbp.1387}
}
Kostenlos starten →